arginine vasopressin has been researched along with Cardiac Remodeling, Ventricular in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Chen, S; Cui, H; Du, GQ; Li, Y; Shen, W; Sun, P; Wang, C; Xue, JY; Zhao, P | 1 |
Akers, SR; Ansari, B; Chirinos, JA; Fedorova, OV; Hussain, A; Lakatta, EG; Lee, J; Mustafa, A; Oldland, G; Sardana, M; Wei, W | 1 |
Iwao, H; Izumi, Y; Miura, K | 1 |
Chen, X; Gao, X; Li, Q; Lu, G; Tang, K | 1 |
Isnard, R | 1 |
Aizawa, Y; Kodama, M; Ma, M; Palaniyandi, SS; Veeraveedu, PT; Watanabe, K; Yamaguchi, K | 1 |
Cohn, JN | 1 |
2 review(s) available for arginine vasopressin and Cardiac Remodeling, Ventricular
Article | Year |
---|---|
Therapeutic potential of vasopressin-receptor antagonists in heart failure.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzamides; Benzazepines; Body Water; Clinical Trials as Topic; Disease Models, Animal; Heart Failure; Homeostasis; Humans; Hyponatremia; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan; Ventricular Remodeling | 2014 |
Left ventricle and arteries: structure, function, hormones, and disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arginine Vasopressin; Drug Combinations; Epinephrine; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nitroprusside; Prazosin; Randomized Controlled Trials as Topic; Renin; Renin-Angiotensin System; Stroke Volume; Survival Analysis; Time Factors; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Remodeling | 2001 |
5 other study(ies) available for arginine vasopressin and Cardiac Remodeling, Ventricular
Article | Year |
---|---|
Melatonin activates the Mst1-Nrf2 signaling to alleviate cardiac hypertrophy in pulmonary arterial hypertension.
Topics: Animals; Antioxidants; Arginine Vasopressin; Cysteine; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Hepatocyte Growth Factor; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Malondialdehyde; Melatonin; Monocrotaline; NF-E2-Related Factor 2; Proto-Oncogene Proteins; Pulmonary Arterial Hypertension; Rats; RNA, Small Interfering; Ventricular Remodeling | 2022 |
Association of arginine vasopressin with low atrial natriuretic peptide levels, left ventricular remodelling, and outcomes in adults with and without heart failure.
Topics: Aged; Arginine Vasopressin; Atrial Natriuretic Factor; Biomarkers; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Prognosis; Prospective Studies; Severity of Illness Index; Ventricular Remodeling | 2018 |
The secretion patterns and roles of cardiac and circulating arginine vasopressin during the development of heart failure.
Topics: Aldosterone; Animals; Arginine Vasopressin; Disease Models, Animal; Heart Failure; Male; Myocardium; Rats; Rats, Wistar; Ventricular Remodeling | 2015 |
[Pathophysiology of heart failure for clinicians].
Topics: Algorithms; Arginine Vasopressin; Blood Pressure; Cardiac Output, Low; Cardiomegaly; Endothelins; Heart; Heart Diseases; Heart Failure; Heart Failure, Diastolic; Heart Failure, Systolic; Humans; Pressoreceptors; Prognosis; Renin-Angiotensin System; Sympathetic Nervous System; Vasoconstrictor Agents; Ventricular Remodeling | 2010 |
Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
Topics: Aldosterone; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Pressure; Body Weight; Creatinine; Diuretics; Echocardiography; Furosemide; Heart Failure; Heart Rate; Male; Organ Size; Osmolar Concentration; Potassium; Rats; Rats, Inbred Lew; Renin; Sodium; Tolvaptan; Ventricular Remodeling | 2008 |